Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis

Launched by UNIVERSITY OF MARYLAND, BALTIMORE · Jun 27, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help people with psychotic disorders who are at risk of suicide. The researchers want to focus on a problem called emotion dysregulation, which means having trouble managing your feelings. People with psychotic disorders often struggle with their emotions, and this can increase their risk of suicide. The study aims to create and test an intervention that helps these individuals better regulate their emotions, using advanced methods to gather data about their experiences.

To be eligible for this trial, participants need to be at least 18 years old and diagnosed with a psychotic disorder, showing a serious risk of suicide. They should also be currently receiving mental health support. Participants will be expected to engage in the intervention and share their experiences through surveys. This study is important because it aims to fill a gap in research by focusing on a high-risk group that has not been adequately studied in previous suicide prevention efforts.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • At least 18 years old
• • Psychosis spectrum disorder as assessed by the Mini International Neuropsychiatric Interview (MINI) for Psychotic Disorder Studies
• • Heightened suicide risk as determined by a score of 8+ on the Suicide Behaviors Questionnaire-Revised (SBQ-R). This cutoff may be revised downwards (toward lower suicide risk) if recruitment appears difficult, but will not be revised upwards.
• • Enrollment and engagement in outpatient mental health services with at least one mental health service in the previous month
• • 6+ grade equivalent reading level as assessed by the Wide Range Achievement Test 4 (WRAT-4)
• Exclusion Criteria:
• • Chart diagnosis of intellectual disability (DSM5 317, 318), traumatic brain injury, or deafness.